Trial Information
Summary: Is insomnia stealing your ZZZs?
HOPE Research Institute is currently enrolling adults in a
clinical research study evaluating the safety and effectiveness of
an investigational medication for the treatment of primary
insomnia. This study is being conducted at the address below in
Phoenix, Arizona.
Qualified study participants will receive study supervision by a
board-certified neurologist, study-related exams and tests, as well
as study medication at no charge. Also, qualified participants will
receive compensation for their time and travel.
Eligibility Criteria:
- Adults at least 18 years old who currently have
insomnia.
|
Contact:
Hope Research Institute, LLC
3120 E. Union Hills Drive, Suite 201
Phoenix, AZ 85050
Telephone: 602-288-4673
Fax: 602-288-4678
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 6:30:40 AM